Terns Pharmaceuticals Stock Soars on Promising Data for CML Therapy
$Terns Pharmaceuticals(TERN)$ stock surged 81.6% in morning trading on Monday after the clinical-stage oncology company reported promising data from its ongoing CARDINAL trial of TERN-701, a novel...